Plasma fibroblast growth factor 21 levels increase with ectopic fat accumulation and its receptor levels are decreased in the visceral fat of patients with type 2 diabetes

Background Fibroblast growth factor 21 (FGF21) is a novel metabolic regulator that has beneficial effects on glucose and lipid metabolism. However, plasma FGF21 levels are paradoxically increased in type 2 diabetes mellitus (T2DM) and obesity, suggesting resistance to this ligand. FGF21 acts mainly...

全面介绍

书目详细资料

Principais autores:	Eun Shil Hong, Cheong Lim, Hye Yeon Choi, Yun Kyung Lee, Eu Jeong Ku, Jae Hoon Moon, Kyong Soo Park, Hak Chul Jang, Sung Hee Choi
格式:	Artigo
语言:	Inglês
出版:	BMJ Publishing Group 2019-05-01
丛编:	BMJ Open Diabetes Research & Care
在线阅读:	https://drc.bmj.com/content/7/1/e000776.full
标签:	添加标签 没有标签, 成为第一个标记此记录!